News for Anavex Life Sciences Corp. (0HFR.L)

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (”œAnavex” or the ”œCompany”) ( AVXL), a clinical-stage biopharmaceutical company

**media[548363]**

Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAVXL.OQ - Anavex Life Sciences CorpQ1 2025 Anavex Life Sciences Corp Earnings CallFeb 12, 2025

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this year. Click for my AVXL stockupdate.

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by midday trading in New York.

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ETCompany ParticipantsClint Tomlinson - IRChristopher...

Company to host a webcast today at 8:30 a.m. Eastern Time NEW YORK, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (”œAnavex” or the ”œComp

NEW YORK, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (”œAnavex” or the ”œCompany”) ( AVXL), a clinical-stage biopharmaceutical company

Blarcamesine potential novel oral treatment to target upstream Alzheimer's disease pathology through autophagy enhancement Impairment of autophagy precedes bot

Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer's Disease

**media[513450]**

Anavex Life Sciences Corp (AVXL), a clinical-stage biopharmaceutical company specializing in treatments for central nervous system (CNS) disorders, announced it

NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (”œAnavex” or the ”œCompany”) ( AVXL), a clinical-stage biopharmaceutical company

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please ...

U.S. stocks were higher, with the Dow Jones index gaining over 100 points on Tuesday. Shares of Greenfire Resources Ltd. GFR rose sharply during Tuesday's sess...

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Monday. Shares of Honda Motor Co., Ltd. HMC rose sharply during Monday's session af...

On Monday, December 23, 2024, the U.S. stock market demonstrated resilience, rebounding from last week's losses. The Dow Jones Industrial Average (DJIA)

U.S. stock futures advanced on Monday as two out of the four major index futures were trading higher in premarket trade.